Skip to main content
OpenTrials
Completed

NCT Number: NCT05940753

Flash Mob Study With Regard to Travel Willingness Among Patients With Cancer

This is a cross-sectional study in the form of a flash mob study, in which an inventory will be made on 13 and 14 March 2023 of the willingness to travel of oncology patients in the participating hospitals. Patients who have an appointment with an internist-oncologist or oncology specialist nurse at the outpatient clinic or by telephone and patients who come to day treatment unit for medical oncology are asked to participate. Willingness to travel is examined by means of a survey, in which a minimal set of categorized patient data (e.g. age, gender, level of education) is collected as part of the survey.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Medical Center Groningen

Groningen, 9713 GZ, Netherlands

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Medical oncology patients with an appointment in the out-patient clinic or day treatment unit on 13 or 14 march 2023
  • Medical oncology patients with an (video) call appointment in the out-patient clinic on 13 or 14 march 2023

Exclusion criteria

  • Patients in the inpatients oncology unit
  • Medical oncology patients with no appointment on 13 or 14 march 2023

Treatment and study plan

Survey about travel willingness regarding cancer treatment and follow-up

Other

No intervention. Willingness to travel is examined through a survey. The survey will be conducted digitally, but may also be done on paper. In the survey a minimal set of categorized patient data (e.g. age, gender, level of education) is collected as part of the survey. For patients who cannot independently complete the questionnaire (for example due to low literacy skills), a volunteer, medical student or researcher is allowed to help the patient.

Primary outcomes

  1. Travel willingness

    Time frame: 1 day

    How far is the oncological patient willing to travel for his/her systemic treatment or follow-up?

Secondary outcomes

  1. Facilitating and inhibiting factors for willingness to travel

    Time frame: 1 day

    What are facilitating and inhibiting factors in patients' willingness to travel?

  2. Which patient characteristics are associated with willingness to travel?

    Time frame: 1 day

    Which patient characteristics are associated with willingness to travel? (age, type of cancer, curative/palliative treatment, distance to nearest hospital)

Sponsors and collaborators

Lead sponsor

University Medical Center Groningen

Other

Registry information

Official study title

Flashmobstudie Landelijke Meting Reisbereidheid Medisch Oncologische Zorg

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jul 11, 2023
Registry last updated
Jul 11, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.